{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T02:00:01Z","timestamp":1755223201185,"version":"3.43.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,11]]},"DOI":"10.7759\/cureus.89796","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T12:38:15Z","timestamp":1754915895000},"source":"Crossref","is-referenced-by-count":0,"title":["miR-145-Mediated Tumor Suppression in Bladder Urothelial Carcinoma via Targeting the ADAMTS5\/Wnt Signaling Axis"],"prefix":"10.7759","author":[{"given":"Jiang","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhang L","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheny Y","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huang","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu","family":"Ming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Jun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel RL","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024, 74:12-49. 10.3322\/caac.21820","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2023.03.029","article-title":"Epidemiology of bladder cancer in 2023: a systematic review of risk factors","volume":"84","author":"Jubber I","year":"2023","unstructured":"Jubber I, Ong S, Bukavina L, et al.. Epidemiology of bladder cancer in 2023: a systematic review of risk factors. Eur Urol. 2023, 84:176-90. 10.1016\/j.eururo.2023.03.029","journal-title":"Eur Urol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101116","article-title":"A distinct subset of urothelial cells with enhanced EMT features promotes chemotherapy resistance and cancer recurrence by increasing COL4A1-ITGB1 mediated angiogenesis","volume":"76","author":"Guo J","year":"2024","unstructured":"Guo J, Ma X, Liu D, et al.. A distinct subset of urothelial cells with enhanced EMT features promotes chemotherapy resistance and cancer recurrence by increasing COL4A1-ITGB1 mediated angiogenesis. Drug Resist Updat. 2024, 76:101116. 10.1016\/j.drup.2024.101116","journal-title":"Drug Resist Updat"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05420-3","article-title":"Hypermethylated TAGMe as a universal-cancer-only methylation marker and its application in diagnosis and recurrence monitoring of urothelial carcinoma","volume":"22","author":"Yang Z","year":"2024","unstructured":"Yang Z, Chen Q, Dong S, et al.. Hypermethylated TAGMe as a universal-cancer-only methylation marker and its application in diagnosis and recurrence monitoring of urothelial carcinoma. J Transl Med. 2024, 22:608. 10.1186\/s12967-024-05420-3","journal-title":"J Transl Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1342996","article-title":"Prognostic and clinicopathological significance of systemic immune-inflammation index in upper tract urothelial carcinoma: a meta-analysis of 3911 patients","volume":"14","author":"Yu Z","year":"2024","unstructured":"Yu Z, Xiong Z, Ma J, et al.. Prognostic and clinicopathological significance of systemic immune-inflammation index in upper tract urothelial carcinoma: a meta-analysis of 3911 patients. Front Oncol. 2024, 14:1342996. 10.3389\/fonc.2024.1342996","journal-title":"Front Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2018.05.020","article-title":"MiRNAs: dynamic regulators of immune cell functions in inflammation and cancer","volume":"431","author":"Hirschberger S","year":"2018","unstructured":"Hirschberger S, Hinske LC, Kreth S. MiRNAs: dynamic regulators of immune cell functions in inflammation and cancer. Cancer Lett. 2018, 431:11-21. 10.1016\/j.canlet.2018.05.020","journal-title":"Cancer Lett"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s40291-019-00410-4","article-title":"MicroRNAs: key players in bladder cancer","volume":"23","author":"Li Q","year":"2019","unstructured":"Li Q, Wang H, Peng H, et al.. MicroRNAs: key players in bladder cancer. Mol Diagn Ther. 2019, 23:579-601. 10.1007\/s40291-019-00410-4","journal-title":"Mol Diagn Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031469","article-title":"Trials and tribulations of microRNA therapeutics","volume":"25","author":"Seyhan AA","year":"2024","unstructured":"Seyhan AA. Trials and tribulations of microRNA therapeutics. Int J Mol Sci. 2024, 25:1469. 10.3390\/ijms25031469","journal-title":"Int J Mol Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13002-x","article-title":"Tissue-specific microRNA expression alters cancer susceptibility conferred by a TP53 noncoding variant","volume":"10","author":"Deng Q","year":"2019","unstructured":"Deng Q, Hu H, Yu X, et al.. Tissue-specific microRNA expression alters cancer susceptibility conferred by a TP53 noncoding variant. Nat Commun. 2019, 10:5061. 10.1038\/s41467-019-13002-x","journal-title":"Nat Commun"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2024.13273","article-title":"SP1\u2011mediated ADAMTS5 transcription promotes IL\u20111\u03b2\u2011induced chondrocyte injury via Wnt\/\u03b2\u2011catenin pathway in osteoarthritis","volume":"30","author":"Hao X","year":"2024","unstructured":"Hao X, Wu X. SP1\u2011mediated ADAMTS5 transcription promotes IL\u20111\u03b2\u2011induced chondrocyte injury via Wnt\/\u03b2\u2011catenin pathway in osteoarthritis. Mol Med Rep. 2024, 30:10.3892\/mmr.2024.13273","journal-title":"Mol Med Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S268222","article-title":"miR-302e suppresses glioma progression by targeting VEGFA","volume":"12","author":"Xie Y","year":"2020","unstructured":"Xie Y, Liu X, Hu T, Wang W. miR-302e suppresses glioma progression by targeting VEGFA. Cancer Manag Res. 2020, 12:10965-74. 10.2147\/CMAR.S268222","journal-title":"Cancer Manag Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21228491","article-title":"Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in glioblastoma cell lines and extracellular vesicles","volume":"21","author":"Zottel A","year":"2020","unstructured":"Zottel A, \u0160amec N, Kump A, et al.. Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in glioblastoma cell lines and extracellular vesicles. Int J Mol Sci. 2020, 21:8491. 10.3390\/ijms21228491","journal-title":"Int J Mol Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxrep.2020.11.001","article-title":"The role of MiRNA-21 in gliomas: hope for a novel therapeutic intervention?","volume":"7","author":"Aloizou AM","year":"2020","unstructured":"Aloizou AM, Pateraki G, Siokas V, et al.. The role of MiRNA-21 in gliomas: hope for a novel therapeutic intervention?. Toxicol Rep. 2020, 7:1514-30. 10.1016\/j.toxrep.2020.11.001","journal-title":"Toxicol Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S289241","article-title":"Circular RNA circDNM3OS functions as a miR-145-5p sponge to accelerate cholangiocarcinoma growth and glutamine metabolism by upregulating MORC2","volume":"14","author":"Su Y","year":"2021","unstructured":"Su Y, Yu T, Wang Y, Huang X, Wei X. Circular RNA circDNM3OS functions as a miR-145-5p sponge to accelerate cholangiocarcinoma growth and glutamine metabolism by upregulating MORC2. Onco Targets Ther. 2021, 14:1117-29. 10.2147\/OTT.S289241","journal-title":"Onco Targets Ther"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2020.12.023","article-title":"Repression of circRNA_000684 inhibits malignant phenotypes of pancreatic ductal adenocarcinoma cells via miR-145-mediated KLF5","volume":"21","author":"Liu X","year":"2021","unstructured":"Liu X, Zhong L, Jiang W, Wen D. Repression of circRNA_000684 inhibits malignant phenotypes of pancreatic ductal adenocarcinoma cells via miR-145-mediated KLF5. Pancreatology. 2021, 21:406-17. 10.1016\/j.pan.2020.12.023","journal-title":"Pancreatology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-021-00775-3","article-title":"Propofol suppresses cell viability, cell cycle progression and motility and induces cell apoptosis of ovarian cancer cells through suppressing MEK\/ERK signaling via targeting circVPS13C\/miR-145 axis","volume":"14","author":"Lu H","year":"2021","unstructured":"Lu H, Zheng G, Gao X, Chen C, Zhou M, Zhang L. Propofol suppresses cell viability, cell cycle progression and motility and induces cell apoptosis of ovarian cancer cells through suppressing MEK\/ERK signaling via targeting circVPS13C\/miR-145 axis. J Ovarian Res. 2021, 14:30. 10.1186\/s13048-021-00775-3","journal-title":"J Ovarian Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202101_24378","article-title":"Blocking VRK2 suppresses pulmonary adenocarcinoma progression via ERK1\/2\/AKT signal pathway by targeting miR-145-5p","volume":"25","author":"Mu Y","year":"2021","unstructured":"Mu Y, Liu WJ, Bie LY, Mu XQ, Zhao YQ. Blocking VRK2 suppresses pulmonary adenocarcinoma progression via ERK1\/2\/AKT signal pathway by targeting miR-145-5p. Eur Rev Med Pharmacol Sci. 2021, 25:145-53. 10.26355\/eurrev_202101_24378","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.matbio.2018.06.002","article-title":"ADAMTS proteins in human disorders","volume":"71","author":"Mead TJ","year":"2018","unstructured":"Mead TJ, Apte SS. ADAMTS proteins in human disorders. Matrix Biol. 2018, 71:225-39. 10.1016\/j.matbio.2018.06.002","journal-title":"Matrix Biol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.23298","article-title":"ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis","volume":"112","author":"Verma P","year":"2011","unstructured":"Verma P, Dalal K. ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis. J Cell Biochem. 2011, 112:3507-14. 10.1002\/jcb.23298","journal-title":"J Cell Biochem"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0676-3","article-title":"The ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family","volume":"16","author":"Kelwick R","year":"2015","unstructured":"Kelwick R, Desanlis I, Wheeler GN, Edwards DR. The ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family. Genome Biol. 2015, 16:113. 10.1186\/s13059-015-0676-3","journal-title":"Genome Biol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.matbio.2014.01.005","article-title":"The multiple, complex roles of versican and its proteolytic turnover by ADAMTS proteases during embryogenesis","volume":"35","author":"Nandadasa S","year":"2014","unstructured":"Nandadasa S, Foulcer S, Apte SS. The multiple, complex roles of versican and its proteolytic turnover by ADAMTS proteases during embryogenesis. Matrix Biol. 2014, 35:34-41. 10.1016\/j.matbio.2014.01.005","journal-title":"Matrix Biol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/s0378-1119(01)00861-7","article-title":"Cloning, expression analysis, and structural characterization of seven novel human ADAMTSs, a family of metalloproteinases with disintegrin and thrombospondin-1 domains","volume":"283","author":"Santiago Cal","year":"2002","unstructured":"Santiago Cal, Alvaro J Obaya, Llamazares M, Garabaya C, Quesada V, L\u00f3pez-Ot\u0131\u0301n C. Cloning, expression analysis, and structural characterization of seven novel human ADAMTSs, a family of metalloproteinases with disintegrin and thrombospondin-1 domains. Gene. 2002, 283:49-62. 10.1016\/s0378-1119(01)00861-7","journal-title":"Gene"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1177\/1533033820986826","article-title":"In silico identification of contradictory role of ADAMTS5 in hepatocellular carcinoma","volume":"20","author":"Zhu Z","year":"2021","unstructured":"Zhu Z, Xu J, Wu X, Lin S, Li L, Ye W, Huang Z. In silico identification of contradictory role of ADAMTS5 in hepatocellular carcinoma. Technol Cancer Res Treat. 2021, 20:1533033820986826. 10.1177\/1533033820986826","journal-title":"Technol Cancer Res Treat"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-46261-1","article-title":"Study of gene expression profiles of breast cancers in Indian women","volume":"9","author":"Malvia S","year":"2019","unstructured":"Malvia S, Bagadi SA, Pradhan D, et al.. Study of gene expression profiles of breast cancers in Indian women. Sci Rep. 2019, 9:10018. 10.1038\/s41598-019-46261-1","journal-title":"Sci Rep"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-005-1032-6","article-title":"Human glioblastomas overexpress ADAMTS-5 that degrades brevican","volume":"110","author":"Nakada M","year":"2005","unstructured":"Nakada M, Miyamori H, Kita D, et al.. Human glioblastomas overexpress ADAMTS-5 that degrades brevican. Acta Neuropathol. 2005, 110:239-46. 10.1007\/s00401-005-1032-6","journal-title":"Acta Neuropathol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/398074-mir-145-mediated-tumor-suppression-in-bladder-urothelial-carcinoma-via-targeting-the-adamts5wnt-signaling-axis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T12:38:16Z","timestamp":1754915896000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/398074-mir-145-mediated-tumor-suppression-in-bladder-urothelial-carcinoma-via-targeting-the-adamts5wnt-signaling-axis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.89796","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,11]]}}}